Innovating Works

BM

Desconocido
STARDUST: in vivo optogeneticS elecTrophysiology and phArmacology with an ultRasonically powered DUST for Par... BIOMODICS APS participó en un H2020: H2020-FETOPEN-2016-2017 The main goal of the STARDUST project is to realize a novel wireless implantable and independent micro-scale device (200x200x200 µm3) enabli...
2017-08-08 - 2022-09-30 | Financiado
Training4CRM: European Training Network for Cell based Regenerative Medicine BIOMODICS APS participó en un H2020: H2020-MSCA-ITN-2016 The main objective of Training4CRM is to train a new generation of 15 highly inter-disciplinary early stage researchers at the highest inter...
2016-09-06 - 2020-10-31 | Financiado
Bacticon1: BACTerial detection and CONtrol of urinary tract infection BIOMODICS APS tramitó un H2020: H2020-SMEInst-2014-2015 Problem Approx. 50% of all patients with severe blood stream infections die from the infections, while the remaining 50% incur excessive so...
2015-02-25 - 2015-04-30 | Financiado
UNICAT: Unique Biomaterial Drug Solution for Multifunctional Central Venous Catheters BIOMODICS APS participó en un H2020: H2020-MSCA-RISE-2014 Central venous catheters (CVCs) play a critical role in healthcare and few medical devices are more important and widespread in modern medic...
2014-11-11 - 2017-12-31 | Financiado
NANOBIO4TRANS: A new nanotechnology based paradigm for engineering vascularised liver tissue for transplantation BIOMODICS APS participó en un FP7: Organ transplantation is often the only life saving medical approach for several diseases, in spite of many associated problems (lack of org...
Financiado
BACATTACK: A stealth attack tool for preventing clinical drug resistance through a unique self regenerating sur... BIOMODICS APS participó en un FP7: Outbreaks of clinical infections affect many thousands of patients in Europe yearly. The present effective treatment for infections is large...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.